Kestra Advisory Services
CTSO icon

Kestra Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

Kestra Advisory Services’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,410
Closed -$10.5K – 3464
2026
Q2 		$10.5K Hold
1,410
– – ﹤0.01% 3247
2026
Q1 		$16K Buy
1,410
+125
+10% +$1.71K ﹤0.01% 3096
2025
Q4 		$16.4K Sell
1,285
-1,941
-60% -$29.9K ﹤0.01% 4526
2025
Q3 		$60.3K Sell
3,226
-318
-9% -$6.26K ﹤0.01% 2850
2025
Q2 		$90.7K Hold
3,544
– – ﹤0.01% 2743
2025
Q1 		$70.9K Buy
3,544
+794
+29% +$16.7K ﹤0.01% 2624
2024
Q4 		$50K Buy
2,750
+2,090
+317% +$41K ﹤0.01% 2608
2024
Q3 		$19.8K Buy
+660
New +$14.5K ﹤0.01% 2529

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $812M AUM 0.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $36.2B AUM 20.53% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Kestra Advisory Services's CTSO Position: Q3 2026 in Review

Kestra Advisory Services sold out of Cytosorbents Corp (CTSO) in Q3 2026, closing a stake of 1,410 shares — an estimated $10.5K sold.

Kestra Advisory Services first reported a position in CTSO in Q3 2024 and held it in 8 quarters. The position peaked at $90.7K in Q2 2025. 25 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • Kestra Advisory Services reported no remaining Cytosorbents Corp position as of Q3 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,410 Cytosorbents Corp shares in Q3 2026, an estimated $10.5K.
  • Kestra Advisory Services first reported a position in Cytosorbents Corp in Q3 2024 and held it in 8 quarters.
  • Kestra Advisory Services's Cytosorbents Corp position peaked at $90.7K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.